Developer docs
API playgroundTry for free, no card

Search company profiles

Mindspan

Full company profile

uuid00n5th4

Namestring
Mindspan
Legal namestring
Mindspan Group, Inc.
Websiteurl
mindspan.co
Company typeenum
Private
Founded yearstring
-
Descriptiontext

Mindspan is a cognitive care and dementia specialist clinic network providing rapid-access neurological evaluation, diagnosis, and ongoing management of memory disorders, mild cognitive impairment, Alzheimer's disease, and related dementias. The company operates in-person specialty memory care clinics in Danvers, Massachusetts and San Jose, California, and accepts referrals through a multi-state affiliated medical practice structure spanning New York, New Jersey, Florida, and California. Its core commercial promise is reducing time-to-specialist from a typical 12-18 months to 2-3 weeks through a freemium digital screening funnel and concentrated neurology capacity.

The platform combines clinical care delivery with a proprietary AI-powered technology stack. Mindy, an AI assessment guide, autonomously administers validated cognitive tests (Montreal Cognitive Assessment, Memory Impairment Screen, Functional Assessment Staging Tool) and produces structured pre-visit summaries. The Cognitive Digital Twin is a personalized predictive model trained on more than 70,000 cognitive care patients and 20 years of research, integrating history, labs, imaging, biomarkers, genetics, and cognitive testing to forecast trajectory and generate care recommendations. Cortex is a plain-language clinical co-pilot for caregivers, and the Orchestration Engine automates care coordination, scan scheduling, and EHR-integrated note delivery to Athena and Epic.

Mindspan generates revenue primarily through insurance reimbursement for specialist visits billed as in-network to Medicare, Medicaid, and commercial plans, supplemented by participation in Medicare's GUIDE dementia care program (which delivers $0 copay visits, 24/7 specialist access via partner Ianacare, and up to $2,500 per year in caregiver respite for eligible Original Medicare patients in MA and CA), clinical trial participation fees, and the Edge Protocol precision medicine add-on (blood biomarker panels, APOE genetic testing, biological disease staging). Customer acquisition combines direct-to-consumer digital channels (website, free online screening), primary care provider referrals through Athena/Epic integrations and fax, and hospital system affiliations including Good Samaritan, El Camino Health, Beverly, and Addison Gilbert.

Short descriptiontext

Mindspan operates a cognitive care clinic network in Massachusetts and California delivering AI-assisted dementia assessment, anti-amyloid therapies, and ongoing care coordination, billed through insurance and Medicare's GUIDE program.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersDanvers, United States
HQ citystring
Danvers
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices8 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
cognitive care services, memory loss treatment, Alzheimer's disease care, dementia specialty clinics, neurological assessment services
Industry4 codes
PRIMARYHLADALAF
Dementia/Alzheimer’s Care Management & Behavioral Support
Healthcare & Life Sciences/Elder Care & Long-Term Care/Senior Care Coordination & Case Management (Geriatric Care Management)
SECONDARYHLAKAIAH
Cognitive & Behavioral Neurology (Dementia/Memory Disorders)
SECONDARYHLADACAJ
Memory Care Care Management & Navigation (Dementia Care Coordination)
Healthcare & Life Sciences/Elder Care & Long-Term Care/Memory Care (Dementia/Alzheimer’s) Communities
SECONDARYHSABAEAJ
Dementia Care Coordination & Care Planning
Home & Personal Services/Elder Care & In-Home Care Services/Dementia & Alzheimer’s In-Home Care
NAICS code3 codes
  • Offices of Physicians, Mental Health Specialists621112
  • Services for the Elderly and Persons with Disabilities62412
  • Services for the Elderly and Persons with Disabilities624120
SIC code3 codes
  • Services-Offices & Clinics Of Doctors Of Medicine8011
  • Services-Specialty Outpatient Facilities, Nec8093
  • Services-Health Services8000
Product category
Memory Disorder and Cognitive Care Clinics
No data
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model3 records
1Insurance Reimbursement
TypeSubscription Recurring
Description

Mindspan bills Medicare, Medicaid, and many health plans as an in-network specialist. Visits are billed the same way as any neurologist or specialist appointment, with the company handling prior authorizations and insurance paperwork. GUIDE program participants on Original Medicare pay $0 for covered visits.

mindspan.co
2GUIDE Program (Medicare Dementia Care Benefit)
TypeManaged Services
Description

Medicare-supported coordinated dementia care model providing $0 copay visits, 24/7 specialist access, respite benefits up to $2,500/year, and dedicated care coordination for qualifying Original Medicare patients with dementia diagnosis in MA or CA.

mindspan.co
3Clinical Trial Participation
TypeProfessional Services
Description

Mindspan offers participation in clinical trials as part of its care model, providing access to cutting-edge therapies and research while generating additional revenue streams.

mindspan.co
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels5 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Technology or R&D, Marketing or Sales, Supply Chain
Pricing details3 tiers
1Free at-home cognitive screening
ModelFreemiumBilling cadencePay-as-you-go
Notes

30-minute at-home screening at no cost, no account required. Results delivered same day with plain-language summary.

mindspan.co
2Standard specialist visits (insurance-covered)
ModelSubscriptionBilling cadenceAnnual
Notes

Billed through Medicare, Medicaid, and many health plans. $0 copays for GUIDE program participants on Original Medicare with dementia diagnosis.

mindspan.co
3GUIDE Program - Medicare dementia care benefit
ModelSubscriptionBilling cadenceAnnual
Notes

Medicare-supported model providing $0 copays for covered visits, up to $2,500/year respite benefits, 24/7 specialist access, and dedicated care coordinator at no additional cost to eligible patients.

mindspan.co
GTM typeB2C
B2C
Offering typeServices
Services
Brand1 of 3 records shown
1Mindy
Description

AI-powered cognitive assessment guide that walks patients through screening tests including Montreal Cognitive Assessment, Memory Impairment Screen, and Functional Assessment Staging Tool.

mindspan.co
+2 more records
Core offering1 text field

Mindspan operates specialty neurology clinics providing cognitive care for memory loss, Alzheimer's, and dementia, delivering same-day AI-assisted cognitive screening, board-certified neurologist visits within 2-3 weeks, advanced diagnostics (blood biomarkers, APOE genetic testing, MRI/PET imaging), FDA-approved anti-amyloid therapies (Leqembi, Kisunla), and ongoing care coordination. Care is enabled by a proprietary AI platform (Mindy assessment guide, Cognitive Digital Twin, Cortex co-pilot, orchestration engine) and billed through Medicare, Medicaid, and commercial health plans, with $0 copays for eligible Medicare GUIDE program participants.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • Patients see a neurologist within 2-3 weeks compared to 12+ months typical specialist wait time
+2 more records
Product overview1 text field

Mindspan is a cognitive care clinic network — not a single software product but a care delivery platform combining in-person specialist neurology with a suite of proprietary AI-powered tools. The core offering is a specialist neurology practice (Mindspan) with clinics in Danvers, MA and San Jose, CA, delivering the Core Protocol (standard neurological care with cognitive testing, imaging, and FDA-approved therapies Leqembi and Kisunla) and the Edge Protocol (precision medicine add-on with blood biomarkers, APOE testing, and biological staging). Patient-facing AI tools include Mindy (autonomous cognitive assessment guide), the Cognitive Digital Twin (predictive trajectory model), and Cortex (plain-language clinical co-pilot). Care coordination is handled by the orchestration engine, which auto-tracks follow-ups and delivers EHR notes to Athena/Epic. Mindspan also offers the GUIDE Program, a Medicare dementia care benefit providing 24/7 specialist access, respite credits, and $0 copays for eligible patients. Patients access care via a free at-home screening, the Patient Portal (my.mindspan.co), or through a Clinical Referrer Portal integrated with Athena and Epic.

Product and service7 records
1Mindspan Specialty Cognitive Care Clinics
CategorySpecialty Neurology / Cognitive Care Clinics
2Core Protocol
CategoryClinical Care Protocol
3Edge Protocol
CategoryPrecision Medicine Add-on
4GUIDE Program
CategoryMedicare Coordinated Care Program
5Free At-Home Cognitive Screening
CategoryDigital Screening / Assessment
6Patient Portal
CategoryPatient Portal
7Clinical Referrer Portal
CategoryProvider Referral Service
Scale indicator4 records

Each record includes

Type, Value, Description, Source

Partnership2 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-01-01
Description

January 2026 research collaboration to evaluate how Altoida's AI and augmented reality-powered digital NeuroMarker platform integrates into Mindspan's personalized cognitive care delivery model for adults with cognitive concerns. Pilot study enrolling up to 100 adults assessing clinical, operational, and economic impacts including diagnostic efficiency, clinician efficiency, and patient experience. Results intended to inform future clinical, operational, and health economic evaluations.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

GUIDE Partner Organization operating Mindspan's 24/7 specialist-staffed phone line for GUIDE program families. Provides around-the-clock access to dementia care specialists for caregiver questions and urgent concerns at 10pm or on weekends, included as part of Medicare's GUIDE dementia care benefit.

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Linus Health provides digital cognitive assessment tools (e.g., DCTclock) used in primary care and specialty settings for early dementia detection. It overlaps with Mindspan's Mindy assessment guide and at-home screening offering.

TypeBroad incumbent
Description

The Lou Ruvo Center is a large, established specialty center providing memory and dementia care, research, and clinical trials. It is a broader incumbent in the same cognitive care category as Mindspan, with greater scale but less technology-led positioning.

TypeEmerging player
Description

Altoida develops AI and AR-powered digital biomarkers for early Alzheimer's detection. It is both a Mindspan research collaborator (Altoida NeuroMarker Platform, Jan 2026) and an emerging competitor in digital cognitive assessment.

TypeDirect peer
Description

Isaac Health is a specialty memory care and dementia clinic offering at-home and telehealth cognitive evaluations with neurology-led care plans. It competes most directly with Mindspan's dementia specialist clinic + telehealth model.

TypeDirect peer
Description

BrainCheck delivers digital cognitive assessment and care management software used by clinicians to screen, monitor, and manage patients with cognitive impairment — directly comparable to Mindspan's Mindy + orchestration stack.

TypeDirect peer
Description

Neurotrack offers digital cognitive screening and longitudinal brain health tools aimed at early Alzheimer's detection. Its screening-plus-monitoring approach is directly comparable to Mindspan's Mindy and Digital Twin offerings.

TypeBroad incumbent
Description

UCSF's MAC is an academic specialty center for dementia diagnosis, treatment, and research. It competes for complex cognitive patients in the Bay Area (overlapping with Mindspan's San Jose clinic) and represents the established specialist alternative.

8Eisai (Leqembi)
TypeBroad incumbent
Description

Eisai co-develops and commercializes Leqembi (lecanemab), one of the FDA-approved anti-amyloid therapies that Mindspan administers. Eisai's commercial infrastructure and provider networks are both a payer partner and an indirect competitive channel for cognitive care.

TypeBroad incumbent
Description

Eli Lilly manufactures Kisunla (donanemab), the second FDA-approved anti-amyloid therapy delivered at Mindspan. Lilly's own diagnostics and infusion-center investments overlap with Mindspan's specialist delivery model.

TypeBroad incumbent
Description

Mass General Brigham operates a major academic memory disorders program on the same North Shore / Greater Boston geography as Mindspan's Danvers clinic. It represents the established specialist competitor whose long wait times Mindspan explicitly disrupts.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration3 records

Each record includes

Title, Type, Description, Source

AI capability10 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles3 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries6 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Mindspan

Memory Disorder and Cognitive Care Clinicsmindspan.co

Mindspan operates a cognitive care clinic network in Massachusetts and California delivering AI-assisted dementia assessment, anti-amyloid therapies, and ongoing care coordination, billed through insurance and Medicare's GUIDE program.

What Mindspan does

Mindspan is a cognitive care and dementia specialist clinic network providing rapid-access neurological evaluation, diagnosis, and ongoing management of memory disorders, mild cognitive impairment, Alzheimer's disease, and related dementias. The company operates in-person specialty memory care clinics in Danvers, Massachusetts and San Jose, California, and accepts referrals through a multi-state affiliated medical practice structure spanning New York, New Jersey, Florida, and California. Its core commercial promise is reducing time-to-specialist from a typical 12-18 months to 2-3 weeks through a freemium digital screening funnel and concentrated neurology capacity.

The platform combines clinical care delivery with a proprietary AI-powered technology stack. Mindy, an AI assessment guide, autonomously administers validated cognitive tests (Montreal Cognitive Assessment, Memory Impairment Screen, Functional Assessment Staging Tool) and produces structured pre-visit summaries. The Cognitive Digital Twin is a personalized predictive model trained on more than 70,000 cognitive care patients and 20 years of research, integrating history, labs, imaging, biomarkers, genetics, and cognitive testing to forecast trajectory and generate care recommendations. Cortex is a plain-language clinical co-pilot for caregivers, and the Orchestration Engine automates care coordination, scan scheduling, and EHR-integrated note delivery to Athena and Epic.

Mindspan generates revenue primarily through insurance reimbursement for specialist visits billed as in-network to Medicare, Medicaid, and commercial plans, supplemented by participation in Medicare's GUIDE dementia care program (which delivers $0 copay visits, 24/7 specialist access via partner Ianacare, and up to $2,500 per year in caregiver respite for eligible Original Medicare patients in MA and CA), clinical trial participation fees, and the Edge Protocol precision medicine add-on (blood biomarker panels, APOE genetic testing, biological disease staging). Customer acquisition combines direct-to-consumer digital channels (website, free online screening), primary care provider referrals through Athena/Epic integrations and fax, and hospital system affiliations including Good Samaritan, El Camino Health, Beverly, and Addison Gilbert.

Mindspan firmographics

Firmographics
Name
Mindspan
Legal name
Mindspan Group, Inc.
Website
https://mindspan.co
Company type
Private
Operating status
Operating
Headcount range
11–50 employees
Short description
Mindspan operates a cognitive care clinic network in Massachusetts and California delivering AI-assisted dementia assessment, anti-amyloid therapies, and ongoing care coordination, billed through insurance and Medicare's GUIDE program.
Ownership category
akta.pro rank

Mindspan industry classification

Industry
Product category
Memory Disorder and Cognitive Care Clinics
NAICS
Offices of Physicians, Mental Health Specialists (621112), Services for the Elderly and Persons with Disabilities (62412), Services for the Elderly and Persons with Disabilities (624120)
SIC
Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Specialty Outpatient Facilities, Nec (8093), Services-Health Services (8000)
akta.pro industry
PRIMARYHLADALAF
Dementia/Alzheimer’s Care Management & Behavioral Support
Healthcare & Life Sciences/Elder Care & Long-Term Care/Senior Care Coordination & Case Management (Geriatric Care Management)
SECONDARYHLAKAIAH
Cognitive & Behavioral Neurology (Dementia/Memory Disorders)
SECONDARYHLADACAJ
Memory Care Care Management & Navigation (Dementia Care Coordination)
Healthcare & Life Sciences/Elder Care & Long-Term Care/Memory Care (Dementia/Alzheimer’s) Communities
SECONDARYHSABAEAJ
Dementia Care Coordination & Care Planning
Home & Personal Services/Elder Care & In-Home Care Services/Dementia & Alzheimer’s In-Home Care

Keywords

  • Cognitive care services
  • Memory loss treatment
  • Alzheimer's disease care
  • Dementia specialty clinics
  • Neurological assessment services

Where Mindspan is headquartered

Location

Headquarters

HQ city
Danvers
HQ country
United States
HQ region
North America

Offices8 records

Markets served

Mindspan business model

Business model
GTM type
B2C
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Marketing or Sales, Supply Chain

Revenue model

  1. Insurance Reimbursement: Mindspan bills Medicare, Medicaid, and many health plans as an in-network specialist. Visits are billed the same way as any neurologist or specialist appointment, with the company handling prior authorizations and insurance paperwork. GUIDE program participants on Original Medicare pay $0 for covered visits.
  2. GUIDE Program (Medicare Dementia Care Benefit): Medicare-supported coordinated dementia care model providing $0 copay visits, 24/7 specialist access, respite benefits up to $2,500/year, and dedicated care coordination for qualifying Original Medicare patients with dementia diagnosis in MA or CA.
  3. Clinical Trial Participation: Mindspan offers participation in clinical trials as part of its care model, providing access to cutting-edge therapies and research while generating additional revenue streams.

Pricing tiers

ModelBillingPrice
FreemiumPay-as-you-goFree at-home cognitive screening
SubscriptionAnnualStandard specialist visits (insurance-covered)
SubscriptionAnnualGUIDE Program - Medicare dementia care benefit

Go-to-market motion2 records

Distribution channels5 records

Marketing channels6 records

Mindspan product offering

Product offering

Core offering

Mindspan operates specialty neurology clinics providing cognitive care for memory loss, Alzheimer's, and dementia, delivering same-day AI-assisted cognitive screening, board-certified neurologist visits within 2-3 weeks, advanced diagnostics (blood biomarkers, APOE genetic testing, MRI/PET imaging), FDA-approved anti-amyloid therapies (Leqembi, Kisunla), and ongoing care coordination. Care is enabled by a proprietary AI platform (Mindy assessment guide, Cognitive Digital Twin, Cortex co-pilot, orchestration engine) and billed through Medicare, Medicaid, and commercial health plans, with $0 copays for eligible Medicare GUIDE program participants.

Product overview

Mindspan is a cognitive care clinic network — not a single software product but a care delivery platform combining in-person specialist neurology with a suite of proprietary AI-powered tools. The core offering is a specialist neurology practice (Mindspan) with clinics in Danvers, MA and San Jose, CA, delivering the Core Protocol (standard neurological care with cognitive testing, imaging, and FDA-approved therapies Leqembi and Kisunla) and the Edge Protocol (precision medicine add-on with blood biomarkers, APOE testing, and biological staging). Patient-facing AI tools include Mindy (autonomous cognitive assessment guide), the Cognitive Digital Twin (predictive trajectory model), and Cortex (plain-language clinical co-pilot). Care coordination is handled by the orchestration engine, which auto-tracks follow-ups and delivers EHR notes to Athena/Epic. Mindspan also offers the GUIDE Program, a Medicare dementia care benefit providing 24/7 specialist access, respite credits, and $0 copays for eligible patients. Patients access care via a free at-home screening, the Patient Portal (my.mindspan.co), or through a Clinical Referrer Portal integrated with Athena and Epic.

Differentiator

Problem solved

Functional benefit

Brands

  • Mindy: AI-powered cognitive assessment guide that walks patients through screening tests including Montreal Cognitive Assessment, Memory Impairment Screen, and Functional Assessment Staging Tool.
  • The Digital Twin
  • Cortex

Products and services

  • Mindspan Specialty Cognitive Care Clinics
  • Core Protocol
  • Edge Protocol
  • GUIDE Program
  • Free At-Home Cognitive Screening
  • Patient Portal
  • Clinical Referrer Portal

Quantifiable outcome

  • Patients see a neurologist within 2-3 weeks compared to 12+ months typical specialist wait time
  • +2 more outcomes

Companies that use Mindspan

Customer profile

Named customers3 records

Segments4 records

Ideal customer profiles4 records

Mindspan technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration3 records

AI capability10 records

Feature5 records

Mindspan partnerships and signals

Strategic signal

Partnerships

Two partnerships are on record, tiered core.

  • AltoidacoreStrategic or Co-development Partner · 1 January 2026January 2026 research collaboration to evaluate how Altoida's AI and augmented reality-powered digital NeuroMarker platform integrates into Mindspan's personalized cognitive care delivery model for adults with cognitive concerns. Pilot study enrolling up to 100 adults assessing clinical, operational, and economic impacts including diagnostic efficiency, clinician efficiency, and patient experience. Results intended to inform future clinical, operational, and health economic evaluations.
  • IanacarecoreStrategic or Co-development PartnerGUIDE Partner Organization operating Mindspan's 24/7 specialist-staffed phone line for GUIDE program families. Provides around-the-clock access to dementia care specialists for caregiver questions and urgent concerns at 10pm or on weekends, included as part of Medicare's GUIDE dementia care benefit.

Scale indicators4 records

Recent moves7 records

Expansion highlights5 records

Mindspan competitors and assessment

Company assessment

Direct peers

  • Linus Health: Linus Health provides digital cognitive assessment tools (e.g., DCTclock) used in primary care and specialty settings for early dementia detection. It overlaps with Mindspan's Mindy assessment guide and at-home screening offering.
  • Isaac Health: Isaac Health is a specialty memory care and dementia clinic offering at-home and telehealth cognitive evaluations with neurology-led care plans. It competes most directly with Mindspan's dementia specialist clinic + telehealth model.
  • BrainCheck: BrainCheck delivers digital cognitive assessment and care management software used by clinicians to screen, monitor, and manage patients with cognitive impairment — directly comparable to Mindspan's Mindy + orchestration stack.
  • Neurotrack: Neurotrack offers digital cognitive screening and longitudinal brain health tools aimed at early Alzheimer's detection. Its screening-plus-monitoring approach is directly comparable to Mindspan's Mindy and Digital Twin offerings.

Broad incumbents

  • Cleveland Clinic Lou Ruvo Center for Brain Health: The Lou Ruvo Center is a large, established specialty center providing memory and dementia care, research, and clinical trials. It is a broader incumbent in the same cognitive care category as Mindspan, with greater scale but less technology-led positioning.
  • UCSF Memory and Aging Center: UCSF's MAC is an academic specialty center for dementia diagnosis, treatment, and research. It competes for complex cognitive patients in the Bay Area (overlapping with Mindspan's San Jose clinic) and represents the established specialist alternative.
  • Eisai (Leqembi): Eisai co-develops and commercializes Leqembi (lecanemab), one of the FDA-approved anti-amyloid therapies that Mindspan administers. Eisai's commercial infrastructure and provider networks are both a payer partner and an indirect competitive channel for cognitive care.
  • Eli Lilly (Kisunla): Eli Lilly manufactures Kisunla (donanemab), the second FDA-approved anti-amyloid therapy delivered at Mindspan. Lilly's own diagnostics and infusion-center investments overlap with Mindspan's specialist delivery model.
  • Mass General Brigham Memory Disorders Unit: Mass General Brigham operates a major academic memory disorders program on the same North Shore / Greater Boston geography as Mindspan's Danvers clinic. It represents the established specialist competitor whose long wait times Mindspan explicitly disrupts.

Emerging players

  • Altoida: Altoida develops AI and AR-powered digital biomarkers for early Alzheimer's detection. It is both a Mindspan research collaborator (Altoida NeuroMarker Platform, Jan 2026) and an emerging competitor in digital cognitive assessment.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

Mindspan financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Mindspan leadership team

Management profile

Number of profiles

Profiles3 records

Mindspan subsidiaries and ownership

Company hierarchy

Subsidiaries6 records

Mindspan funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Mindspan M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Mindspan

What does Mindspan do?

Mindspan operates specialty neurology clinics providing cognitive care for memory loss, Alzheimer's, and dementia, delivering same-day AI-assisted cognitive screening, board-certified neurologist visits within 2-3 weeks, advanced diagnostics (blood biomarkers, APOE genetic testing, MRI/PET imaging), FDA-approved anti-amyloid therapies (Leqembi, Kisunla), and ongoing care coordination. Care is enabled by a proprietary AI platform (Mindy assessment guide, Cognitive Digital Twin, Cortex co-pilot, orchestration engine) and billed through Medicare, Medicaid, and commercial health plans, with $0 copays for eligible Medicare GUIDE program participants.

Is Mindspan a public or private company?

Mindspan is a private company. It is classified as unknown and is currently operating.

When was Mindspan founded?

Mindspan was founded in -1. It employs 11 to 50 people.

Where is Mindspan based?

Mindspan is headquartered in Danvers, United States, in the North America region.

How does Mindspan make money?

Three revenue lines are on record. Insurance Reimbursement is the primary driver. The others are GUIDE Program (Medicare Dementia Care Benefit) and clinical Trial Participation.

Who are Mindspan's main competitors?

Direct peers on record are Linus Health, Isaac Health, BrainCheck and Neurotrack. Broad incumbents are Cleveland Clinic Lou Ruvo Center for Brain Health, UCSF Memory and Aging Center, Eisai (Leqembi), Eli Lilly (Kisunla) and Mass General Brigham Memory Disorders Unit. Altoida is listed as an emerging player.

Does Mindspan have an API?

No public API is recorded for Mindspan.

What industry is Mindspan in?

Mindspan's product category is Memory Disorder and Cognitive Care Clinics. Its primary akta.pro industry code is HLADALAF, Dementia/Alzheimer’s Care Management & Behavioral Support, with a secondary code of HLAKAIAH, Cognitive & Behavioral Neurology (Dementia/Memory Disorders). Its NAICS code is 621112 and its SIC code is 8011.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
EIN PresswireDigital Biomarkers Market Growth Accelerates at 22.1% CAGR Through 2033 | Persistence Market ResearchThe global digital biomarkers market is projected to grow from US$4.6 billion in 2026 to US$18.7 billion by 2033, representing a 22.1% CAGR, driven by wearable adoption, AI advancements, aging populations, and rising chronic disease prevalence. North America currently leads the market with 45.5% share in 2025, supported by FDA regulatory frameworks and Medicare reimbursements, while Asia-Pacific is emerging as the fastest-growing region. Key industry developments include ActiGraph's acquisition of Biofourmis Life Sciences to enhance decentralized clinical trials and Altoida's AI cognitive assessment partnership with Mindspan.GlobeNewswireCognitive Assessment & Training in Healthcare Market to Surge at 27.06% CAGR, Reaching USD 73.08 Billion by 2034The global cognitive assessment and training in healthcare market is projected to grow from USD 10.75 billion in 2026 to USD 73.08 billion by 2034, expanding at a compound annual growth rate of 27.06%, driven by rising Alzheimer's and dementia cases, increased mental health awareness, and the integration of AI and machine learning technologies. North America led the market in 2024 due to robust healthcare infrastructure and digital health adoption, while the Asia-Pacific region is expected to witness the fastest growth, supported by government initiatives such as China's "AI Plus" healthcare program and dementia plans. Key market players including Dr Dangs Lab, Altoida, Mindspan, Neurogen Biomarking, and Aster DM Healthcare have recently launched products and partnerships to expand their cognitive health capabilities.Longevity.TechnologyAltoida and Mindspan to study AI/AR cognitive assessment in real-world careAltoida and Mindspan have announced a research collaboration to evaluate how Altoida's AI and augmented reality-powered digital NeuroMarker platform can be integrated into Mindspan's personalized cognitive care delivery model for adults with cognitive concerns. The pilot study will enroll up to 100 adults and assess clinical, operational, and economic impacts including diagnostic efficiency, clinician efficiency, and patient experience. Results from the pilot, expected to begin in the first quarter of 2026, are intended to inform future clinical, operational, and health economic evaluations.